Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 9 studies | 36% ± 24% | |
oligodendrocyte precursor cell | 8 studies | 26% ± 11% | |
astrocyte | 7 studies | 24% ± 7% | |
interneuron | 5 studies | 42% ± 27% | |
GABAergic neuron | 5 studies | 49% ± 19% | |
neuron | 4 studies | 22% ± 5% | |
retina horizontal cell | 4 studies | 22% ± 4% | |
GABAergic interneuron | 3 studies | 27% ± 3% | |
granule cell | 3 studies | 22% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 7 studies | 32% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 98% | 1669.62 | 2585 / 2642 | 98% | 42.18 | 693 / 705 |
ovary | 83% | 455.85 | 149 / 180 | 98% | 55.57 | 421 / 430 |
breast | 86% | 598.88 | 393 / 459 | 86% | 21.71 | 960 / 1118 |
thymus | 99% | 691.21 | 644 / 653 | 53% | 7.70 | 323 / 605 |
adrenal gland | 77% | 371.87 | 198 / 258 | 70% | 27.09 | 160 / 230 |
uterus | 96% | 841.34 | 163 / 170 | 36% | 6.96 | 163 / 459 |
kidney | 100% | 1616.37 | 89 / 89 | 25% | 4.97 | 228 / 901 |
lung | 92% | 562.79 | 530 / 578 | 26% | 2.83 | 300 / 1155 |
intestine | 100% | 1260.31 | 965 / 966 | 18% | 1.43 | 93 / 527 |
pancreas | 62% | 191.39 | 204 / 328 | 51% | 4.77 | 90 / 178 |
esophagus | 90% | 614.65 | 1304 / 1445 | 22% | 2.23 | 41 / 183 |
spleen | 100% | 1735.55 | 241 / 241 | 0% | 0 | 0 / 0 |
prostate | 87% | 379.57 | 214 / 245 | 8% | 0.63 | 40 / 502 |
bladder | 71% | 253.33 | 15 / 21 | 11% | 1.19 | 57 / 504 |
stomach | 63% | 306.92 | 226 / 359 | 19% | 1.87 | 54 / 286 |
heart | 77% | 602.92 | 663 / 861 | 0% | 0 | 0 / 0 |
adipose | 68% | 549.95 | 813 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 65% | 6.18 | 52 / 80 |
peripheral blood | 64% | 348.72 | 597 / 929 | 0% | 0 | 0 / 0 |
liver | 27% | 69.98 | 60 / 226 | 19% | 2.35 | 78 / 406 |
muscle | 28% | 72.21 | 223 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 23% | 77.28 | 313 / 1335 | 0% | 0 | 0 / 0 |
skin | 6% | 16.03 | 117 / 1809 | 10% | 1.19 | 46 / 472 |
tonsil | 0% | 0 | 0 / 0 | 9% | 0.54 | 4 / 45 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.29 | 1 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0007155 | Biological process | cell adhesion |
GO_0005615 | Cellular component | extracellular space |
GO_0031012 | Cellular component | extracellular matrix |
GO_0016020 | Cellular component | membrane |
GO_0038023 | Molecular function | signaling receptor activity |
Gene name | LRRN2 |
Protein name | Leucine-rich repeat neuronal protein 2 (Glioma amplified on chromosome 1 protein) (Leucine-rich repeat neuronal protein 5) |
Synonyms | UNQ256/PRO293 LRRN5 GAC1 |
Description | |
Accessions | O75325 ENST00000367177.4 ENST00000367175.1 ENST00000367176.7 |